Home Casma Therapeutics

Casma Therapeutics

In operation
Series C
Biological Therapy Developer
Basic
Enterprise Profile

Basic Information

Casma Therapeutics is leveraging the natural cellular process of autophagy to open up vast new target areas for drug discovery and development. Casma employs multiple approaches to intervene at key points in the autophagy-lysosome system, improving and enhancing membrane repair and clearing unwanted proteins, aggregates, organelles, and invading pathogens from cellular processes. By enhancing autophagy, Casma is expected to be able to halt or reverse the progression of diseases such as lysosomal storage disorders, muscular disorders, cancer, inflammatory conditions, and neurodegeneration.
Casma Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2017
contact@casmatx.com

Enterprise Profile

Industrial Sector
New Drug Development Drug Trial Manufacture of Chemical Pharmaceutical Preparations Manufacture of Biological Pharmaceutical Products
Technology
Gene Technology Targeted Technology Protein Technology
Concept
# Brain Sciences Disease Treatment Tumor # Nervous System Diseases
Application Scenarios
Biologics Chemical Drug Innovative Drugs